MCB

Erik Nelson, professor of molecular and integrative physiology, has won a $4.5 million Era of Hope Scholar Award from the United States Department of Defense Breast Cancer Research Program.This prestigious award supports individuals early in their careers who have demonstrated significant potential...

The winners are being honored during LAS Impact 2020, a weeklong celebration of the College of Liberal Arts & Sciences starting on Oct. 26.

Since the outbreak of the novel coronavirus pandemic, University of Illinois alumnus David Townsend (BS ’88, microbiology) and members of his team at IDEXX Laboratories have developed a test to monitor the presence of SARS-CoV-2 in wastewater that rapidly detects the virus’ genetic material.

Congratulations to Brian Freeman, professor of cell and developmental biology at the University of Illinois who has been selected as a fellow of the Cell Stress Society International.

This announcement was made as part of The News-Gazette’s 13th annual Forty Under 40 Awards. Professor Brooke is an assistant professor of microbiology and is an affiliate of the Carl R. Woese Institute for Genomic Biology.

Danielle Campbell, a microbiology PhD graduate of the Whitaker Lab, recently studied the interaction of the active prophage, Bacteroides phage BV01, in its tractable host strain, B. vulgatus ATCC 8482. Bacteroides, known to degrade complex carbohydrates and interact with host immune cells, are one...

In a recently published study from the University of Illinois, researchers have identified a new class of bacterial importers in over 250 species.

URBANA—University of Illinois professor Andrew Belmont has received two new grants from the National Institutes of Health that will advance his work in understanding nuclear structure and dynamics and gene expression.

New research from University of Illinois professor William Brieher has uncovered new insights on actin disassembly.

University of Illinois researchers are leading the science behind a new global licensing agreement between the pharmaceutics company Bayer AG and the cancer drug development company Systems Oncology for a new breast cancer drug called ERSO.